v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 41,760,511 $ 3,101,859
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 101,934 92,959
Stock compensation expense 180,404 182,958
Changes in operating assets and liabilities:    
Accounts receivable (50,009,850) (4,009,700)
Prepaid expenses and other current assets (95,806) 63,130
Deferred offering costs 6,269
Intangible assets 12,500
Accounts payable 2,080,822 52,727
Accrued compensation and benefits 16,007 (33,886)
Accrued liabilities 5,080,905 (6,109)
Operating lease liabilities (97,018) (83,044)
Net cash used in operating activities (982,091) (645,337)
Cash flows from investing activities:    
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from issuance of common stock, net of issuance costs 480,000
Proceeds from short term insurance financing 230,176 284,304
Payments on short term insurance financing (109,123) (117,986)
Net cash provided by financing activities 601,053 166,318
Effects of exchange rates on cash (1,023)
Net decrease in cash, cash equivalents and restricted cash (382,061) (479,019)
Cash and cash equivalents and restricted cash at beginning of period 833,539 1,612,915
Cash and cash equivalents and restricted cash at end of period 451,478 1,133,896
Supplemental disclosure of cash flow information    
Cash paid for interest $ 3,009 $ 4,861